Related Experiment Video
Updated: May 6, 2026
Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
Rotational vs. laser atherectomy in Chinese CTO-PCI: lesion-specific efficacy with comparable midterm safety
Liansheng Chen1, Zehan Huang1, Quanmin Wu1
1Department of Catheterization Lab, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Background:
Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) often requires plaque modification for device delivery. While rotational atherectomy (RA) and excimer laser coronary atherectomy (ELCA) are established adjuncts, their comparative efficacy and safety remain underexplored in Chinese populations.
Methods:
This single-center retrospective study included 75 consecutive CTO-PCI patients treated with ELCA (n = 25) or RA (n = 50). Procedural success, complications, and major adverse cardiovascular and cerebrovascular events (MACCE) were analyzed over a median 17.5-month follow-up. Multivariable Cox regression adjusted for calcification severity, lesion length, ISR-CTO, and diabetes mellitus.
Results:
RA was preferred for moderate/severe calcification (76% vs. 48%, p = 0.020), while ELCA dominated in ISR-CTO (20% vs. 2%, p = 0.024) and lesions >20 mm (56% vs. 30%, p = 0.044). Procedural success was comparable (RA 90% vs. ELCA 84%, p = 0.706). Procedure-related complications differed: RA had two coronary perforations (4% vs. 0%, p = 0.130), whereas ELCA showed a trend toward more transient slow/no-reflow (12% vs. 0%, p = 0.061). MACCE rates remained similar (19% vs. 13.3%, p = 0.815; adjusted HR 1.53, 95% CI 0.35-6.65, p = 0.569). Both techniques exhibited comparable procedural duration and radiation exposure (all p > 0.05). ELCA incurred higher total costs (US11,147 vs. 9,267, p = 0.007), driven by laser catheter expenses; however, procedural costs became comparable after excluding catheter-related expenditures (p = 0.210).
Conclusion:
In Chinese CTO-PCI, ELCA and RA demonstrate lesion-specific utility-ELCA for ISR-CTO and long lesions, RA for calcified lesions-with comparable midterm safety. Procedural costs of ELCA and RA were equivalent in Device-excluded costs analysis.
